{
  "id": 3895189,
  "title": "US-Klagen: US-Gericht weist Einspruch gegen Milliarden-Vergleich von Bayer zu Roundup ab",
  "url": "https://urgent.news/2026/08/28/us-klagen-us-gericht-weist-einspruch-gegen-milliarden-vergleich-von",
  "topic": "business",
  "section": "Business",
  "published": "2026-08-28T04:51:24.000Z",
  "source": {
    "name": "Handelsblatt",
    "slug": "handelsblatt",
    "url": "https://www.handelsblatt.com/unternehmen/industrie/us-klagen-us-gericht-weist-einspruch-gegen-milliarden-vergleich-von-bayer-zu-roundup-ab/100250301.html"
  },
  "original_language": "de",
  "account": "A US appeals court on Thursday rejected a challenge to a planned $7.25 billion settlement between agricultural and pharmaceutical giant Bayer and plaintiffs over the weed killer Roundup. Plaintiffs had sought to have the case heard by a federal court, whose presiding judge had previously criticized the proposed settlement. The appeals court upheld an earlier decision that the proceedings should remain in a Missouri court, where the judge had earlier tentatively agreed to the agreement. A hearing to finalize approval of the settlement is now set for September 14. The plaintiffs' attorney announced he would continue to challenge the settlement in Missouri. Bayer's lawyer stated that the company intends to pursue the settlement there as well. Monsanto, Bayer's subsidiary, welcomed the decision and called the challenge baseless. The company said the settlement is fair for all parties. The agreement addresses around 65,000 lawsuits filed by individuals who blame the glyphosate-based weed killer for non-Hodgkin lymphoma. The corporation denies the allegations.",
  "summary": "Ein US-Berufungsgericht hat den Einspruch gegen Bayers geplanten 7,25-Milliarden-Dollar-Vergleich im Roundup-Streit abgewiesen. Damit rückt eine endgültige Einigung mit Tausenden Klägern näher.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}